SCHEMBL16349663

SCHEMBL16349663

CC(=O)C(=O)[C@@H]1CCCCCCCCC[C@H](NC(=O)N[C@H](CN(C)S(C)(=O)=O)C(C)(C)C)C(=O)N2C[C@H]3[C@@H]([C@H]2C(=O)N1)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13684933 0.95 — —
SCHEMBL12607100 0.90 — —
SCHEMBL13685071 0.90 — —
SCHEMBL16349617 0.89 MDM2 (0.32) —
SCHEMBL13685066 0.84 MDM2 (0.32) —
SCHEMBL7860522 0.84 — —
SCHEMBL14598541 0.84 — —
SCHEMBL13685615 0.82 CTSV (0.32) —
SCHEMBL13685099 0.82 MDM2 (0.31) —
SCHEMBL12607402 0.82 MDM2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592419-B2 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease SCHERING CORPORATION (US) 2009-09-22 — — US disclosed
Send feedback